samedan logo

 
 
spacer
home > white papers > Financial implications of off-site visits in clinical research, perception versus reality - Illingworth Research
WHITE PAPERS
logo_IllingwortE.jpg

Illingworth Research

phone +44 (0)1625617447
email info@illingworthreseach.com
web http://www.illingworthresearch.com
email Illingworth Research Ltd, Suite 5, Silk House, Park Green, Macclesfield, Cheshire, SK11 7QJ, England

Financial implications of off-site visits in clinical research, perception versus reality

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
Financial implications of off-site visits in clinical research, perception versus reality
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Pfizer announces €300 million investment in Irish operation

Additional 300 headcount in Pfizer's Dublin, Kildare and Cork sites Initial stage of new facility planned for Ringaskiddy site to manufacture medicines for clinical trials
More info >>


White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>


Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement